Clinical Study Of Schizophrenia in Both Men and Women
Status:
Completed
Trial end date:
2005-01-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effectiveness of a marketed drug in the
treatment of schizophrenia, as an add-on therapy to antipsychotics over a 12-week period.
Subjects with schizophrenia who have been maintained on a stable dose of antipsychotics and
who fulfill the screening entrance criteria will have an assessment 1-7 days after the first
visit to confirm eligibility.